About · Team
The people behind Digistain
Physicists, pathologists, oncologists and life-sciences leaders working on recurrence-risk evidence for every patient.
Leadership
Leadership team
Dr Hemmel Amrania
Founder and CEO
Hemmel holds a degree in maths and physics from Imperial College London, a Masters in Optics and Photonics from Université Paris XI, and a PhD on the biomedical applications of ultrafast laser spectroscopy from Imperial College London. During his PhD, Hemmel patented a novel method to grade tumour biopsies. This work was awarded the President’s Award for Outstanding Research at Imperial College and later the Royal Society Innovation Prize and the Cancer Research Pioneer Award. While working on clinical trials at Charing Cross Hospital, Hemmel saw first-hand the challenges breast oncologists faced in determining cancer recurrence risk, and founded Digistain.
Sabrina Ali
Chief Operating Officer
Sabrina graduated from the University of Birmingham with a BSc (Hons) in Chemistry. She has more than 20 years of experience as a pharmaceutical professional, having worked for companies such as GSK and Novartis. For the last 15 years she has worked in oncology.
James Chandler
Chief Marketing Officer
James is a marketing and communications expert with deep experience in the science, healthcare and technology sectors across national and international markets. He has served at executive management level with a number of global communications consultancies, and held senior management positions at BenevolentAI, Sensyne Health plc and e-therapeutics plc.
Clinical board
Clinical board
Prof Chris Phillips
Clinical Board
Chris is the former Dean of the Faculty of Natural Sciences and Head of the Optoelectronics section at Imperial College London. He was a visiting researcher at the Quantum Institute, University of California, Santa Barbara, and is a Fellow of the Institute of Physics. Chris worked with Hemmel Amrania to develop Digistain’s imaging technology.
Sir Nicholas Wright
Clinical Board
Nick is a professor of histopathology, a medical doctor and tumour pathology expert. He is a graduate of Durham Medical School and has two postgraduate degrees in pathology from Newcastle University. He has over 40 years’ experience in tumour pathology at consultant level and is the author of over 300 articles and 9 books. In 2006 he was knighted for services to medicine.
Prof Carlo Palmieri
Clinical Board
Carlo is a Consultant in Medical Oncology. He is a graduate in anatomy and medicine from the University of London and has a PhD from Imperial College London. He has held a Cancer Research UK Clinician Scientist award, is actively involved in translational research trials in breast cancer, and has co-edited the book ‘ABC of Cancer Care’.
Dr Darius Francescatti
Clinical Board
Darius holds a medical degree from Loyola University Chicago Stritch School of Medicine and has been a practising breast oncology surgeon for over 20 years. His professional interest is in advancing technologies to improve surgical outcomes. He is the author of the book ‘Breast Cancer – A New Era of Management’.
Profiles as published on digistain.co.uk. [CONFIRM CURRENT ROLES, BIOS AND PERMISSION TO LIST]